Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl Sublingual Spray for Post-Operative Pain
NCT02915978Phase 2Completed
- Sponsor
- Insys Therapeutics
- Start
- Dec 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fentanyl (transdermal patch + oral transmucosal lozenge) in postoperative pain (3 arms), sponsored by Insys Therapeutics. Primary endpoint: Numeric Rating Scale Summed Pain Intensity Difference Over 0 to 48 Hours. Started Dec 2016; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02915978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02915978.